Scientific article

CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors

Published inNature Immunology, vol. 21, no. 3, p. 298-308
Publication date2020

Depleting regulatory T cells (Treg cells) to counteract immunosuppressive features of the tumor microenvironment (TME) is an attractive strategy for cancer treatment; however, autoimmunity due to systemic impairment of their suppressive function limits its therapeutic potential. Elucidating approaches that specifically disrupt intratumoral Treg cells is direly needed for cancer immunotherapy. We found that CD36 was selectively upregulated in intrautumoral Treg cells as a central metabolic modulator. CD36 fine-tuned mitochondrial fitness via peroxisome proliferator-activated receptor-β signaling, programming Treg cells to adapt to a lactic acid-enriched TME. Genetic ablation of Cd36 in Treg cells suppressed tumor growth accompanied by a decrease in intratumoral Treg cells and enhancement of antitumor activity in tumor-infiltrating lymphocytes without disrupting immune homeostasis. Furthermore, CD36 targeting elicited additive antitumor responses with anti-programmed cell death protein 1 therapy. Our findings uncover the unexplored metabolic adaptation that orchestrates the survival and functions of intratumoral Treg cells, and the therapeutic potential of targeting this pathway for reprogramming the TME.

Affiliation Not a UNIGE publication
Citation (ISO format)
WANG, Haiping et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. In: Nature Immunology, 2020, vol. 21, n° 3, p. 298–308. doi: 10.1038/s41590-019-0589-5
Main files (1)
Article (Published version)
ISSN of the journal1529-2908

Technical informations

Creation03/11/2020 3:20:00 PM
First validation03/11/2020 3:20:00 PM
Update time03/15/2023 9:16:45 PM
Status update03/15/2023 9:16:44 PM
Last indexation08/30/2023 10:22:47 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack